|
Left Zone Top | |
 |
|
| |
Join, share, learn and collaborate 54 leading life science organisations, and growing. Celebrating 10 Years Shaping the Future of Pharmacovigilance |
| |
|
| |
Find out more... |
pvnet |
pvconnect |
|
|
Management Board
Page Content Our staff are drawn from senior management and professional positions in industry. They understand the fine line between implementing radical changes and running a business day-to-day.
To view the profiles of individual members of WCI's Management Board, please see below:
WCI Consulting Limited Management Board
Jon Tims
|
Jon joined WCI as Finance Director in October 1996. He is responsible for the provision of financial direction and information, agreement of client and supplier commercial terms and for all aspects of the back office including finance, HR, IT, insurance, share option scheme and company secretarial duties. Whilst with WCI, Jon has been responsible for agreeing the commercial terms of any corporate restructures, acquisitions and disposals and has built up a wealth of experience in working with solicitors, banks and venture partners on corporate transactions of this nature.
Prior to joining WCI, Jon spent 11 years as finance director of a value added reseller in the computing industry. During this period, as well as running the finance and commercial departments, Jon was involved in a number of acquisitions and disposals as well as being one of the main parties in an MBO and a corporate restructuring.
|
|---|
Chris Holmes
|
Chris has been with WCI for over 15 years and leads the European Practice. He is an experienced business consultant in the European pharmaceutical and Biotechnology industry, and brings leadership, sales, and delivery expertise to global product safety, compliance, and performance programmes.
Chris established WCI's two industry forums, pvnet® and pvconnect® which comprise of over 50 leading life science organisations. The forums monitor performance and compliance, establish best practices, and develop the future of drug safety in response to changing regulatory requirements.
Prior to working in the Life Sciences practice, Chris managed consulting engagements in UK Healthcare, including advising on improvements to patient care and waiting times for a number of NHS Trusts. Chris has a BA (Hons) degree in Business Studies
|
|---|
Mike Giffin
|
Mike joined WCI in 2001 after seven years with Gemini Consulting. For the past sixteen years Mike has focused on the Life Science sector, but also has experience in the FMCG, Financial Services, Energy, and Retail sectors.
His role involves the management of key accounts, and the design and implementation of complex change programmes. He has designed, sold, and led engagements in Europe, the USA, Latam, and Asia. The scope of these engagements has covered Clinical Development, Sales and Marketing, Technical Operations, and Safety.
Prior to consulting, Mike spent seven years as an officer in the British Army. He was a member of the Airborne Artillery and served in Northern Ireland, Belize, Hong Kong, Australia, and Germany. Mike has a BSc in Psychology from University College London, and an MBA from Manchester Business School.
|
|---|
|
|
|
- "The first manet forum demonstrated the value that can be gained from getting together and discussing the challenges that we all face on a daily basis. I\'m convinced that manet will enable operational improvements in our Medical Affairs actitivities"Matthias Müller, SVP Medical Affairs Europe and Australia, Grünenthal
- "WCI\'s experience and knowledge has made a key contribution to the change management process at Nycomed. Their ability to remain focused and work to important timelines has enabled the organisation to move a step closer to its vision"Betina Østergaard Eriksen, VP International Drug Safety, Nycomed
- "The combination of WCI and Sidley Austin LLP\'s depth of experience provides not only a thorough understanding of compliance risks, but also a systems based perspective on how to manage these risks with a view to both current and future regulations"Scott Bass, Partner, Sidley Austin LLP
- "More than just benchmarking, pvnet participation has enabled critical self insight of our PV operations and strategy. pvnet is a forum that develops, rather than just tracks industry trends."John Freeman, Head of Worldwide Drug Safety, Celgene
|
|
|
|
|
|